Tags

Type your tag names separated by a space and hit enter

Usefulness of taurine in chronic congestive heart failure and its prospective application.
Jpn Circ J 1992; 56(1):95-9JC

Abstract

We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%. The changes in echocardiographic parameters produced by 6 weeks of treatment were evaluated in a double-blind fashion. In the taurine-treated group significant treatment effect was observed on systolic left ventricular function after 6 weeks. Such an effect was not observed in the CoQ10-treated group.

Authors+Show Affiliations

Third Department of Internal Medicine, Osaka University Medical School, Japan.

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

1538580

Citation

Azuma, J, et al. "Usefulness of Taurine in Chronic Congestive Heart Failure and Its Prospective Application." Japanese Circulation Journal, vol. 56, no. 1, 1992, pp. 95-9.
Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J. 1992;56(1):95-9.
Azuma, J., Sawamura, A., & Awata, N. (1992). Usefulness of taurine in chronic congestive heart failure and its prospective application. Japanese Circulation Journal, 56(1), pp. 95-9.
Azuma J, Sawamura A, Awata N. Usefulness of Taurine in Chronic Congestive Heart Failure and Its Prospective Application. Jpn Circ J. 1992;56(1):95-9. PubMed PMID: 1538580.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Usefulness of taurine in chronic congestive heart failure and its prospective application. AU - Azuma,J, AU - Sawamura,A, AU - Awata,N, PY - 1992/1/1/pubmed PY - 1992/1/1/medline PY - 1992/1/1/entrez SP - 95 EP - 9 JF - Japanese circulation journal JO - Jpn. Circ. J. VL - 56 IS - 1 N2 - We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%. The changes in echocardiographic parameters produced by 6 weeks of treatment were evaluated in a double-blind fashion. In the taurine-treated group significant treatment effect was observed on systolic left ventricular function after 6 weeks. Such an effect was not observed in the CoQ10-treated group. SN - 0047-1828 UR - https://www.unboundmedicine.com/medline/citation/1538580/Usefulness_of_taurine_in_chronic_congestive_heart_failure_and_its_prospective_application_ L2 - https://medlineplus.gov/heartfailure.html DB - PRIME DP - Unbound Medicine ER -